PTGS2 and neoplasm: Nonsteroidal anti-inflammatory drugs (NSAIDs) as cyclooxygenase-2 (Cox-2) inhibitors (Cox-2i) have shown some anti-tumor activity in general and in GBM experimental models in particular, partly against CSCs [64].